HISCX
Price
$28.05
Change
-$1.05 (-3.61%)
Updated
Feb 21 closing price
Net Assets
536.26M
VISGX
Price
$78.45
Change
-$2.53 (-3.12%)
Updated
Feb 21 closing price
Net Assets
39.59B
Ad is loading...

HISCX vs VISGX

Header iconHISCX vs VISGX Comparison
Open Charts HISCX vs VISGXBanner chart's image
Hartford Small Cap Growth HLS IA
Price$28.05
Change-$1.05 (-3.61%)
VolumeN/A
Net Assets536.26M
Vanguard Small Cap Growth Index I
Price$78.45
Change-$2.53 (-3.12%)
VolumeN/A
Net Assets39.59B
HISCX vs VISGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HISCX vs. VISGX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HISCX is a Hold and VISGX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 39.6B vs. HISCX (536M). VISGX pays higher dividends than HISCX: VISGX (0.55) vs HISCX (0.00). HISCX was incepted earlier than VISGX: HISCX (31 years) vs VISGX (27 years). HISCX has a lower initial minimum investment than VISGX: HISCX (0) vs VISGX (3000). VISGX annual gain was more profitable for investors over the last year : 12.89 vs. HISCX (6.04). VISGX return over 5 years is better than : 35.36 vs. HISCX (-7.82).
HISCXVISGXHISCX / VISGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years27 years-
Gain YTD-3.276-0.343955%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets536M39.6B1%
Annual Yield % from dividends0.000.55-
Returns for 1 year6.0412.8947%
Returns for 3 years-8.6019.23-45%
Returns for 5 years-7.8235.36-22%
Returns for 10 years-3.83115.44-3%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTVE17.830.01
+0.06%
Pactiv Evergreen
TXRH169.13-2.44
-1.42%
Texas Roadhouse
EZPW13.60-0.24
-1.73%
EZCORP
DOUG1.95-0.16
-7.58%
Douglas Elliman
MBRX1.28-0.12
-8.57%
Moleculin Biotech